Massachusetts Marijuana Ballot Question 2026: What Voters Need to Know

Executive Summary

A marijuana legalization ballot question has officially qualified for the November 2026 Massachusetts ballot, receiving its formal ballot number alongside eight other citizen-initiated measures. The question, which survived legal challenges and signature verification, will ask Massachusetts voters whether to expand the state's existing cannabis framework or introduce new regulatory changes to the market established by the 2016 adult-use legalization vote. This marks the first time since Massachusetts voters approved recreational marijuana eight years ago that cannabis policy will return to the statewide ballot. The outcome will have significant implications for the state's $1.5 billion cannabis industry, medical patients, social equity applicants, and neighboring states watching Massachusetts as a bellwether for East Coast cannabis policy. With nine total questions competing for voter attention, cannabis advocates and industry stakeholders face a challenging campaign environment where turnout, messaging, and coalition-building will determine whether Massachusetts expands, restricts, or maintains its current cannabis regulatory structure.

Why This Matters

The 2026 Massachusetts marijuana ballot question affects 7 million residents, 400+ licensed cannabis businesses, and sets precedent for cannabis policy across New England. Massachusetts operates one of the most mature adult-use cannabis markets on the East Coast, with over $1.5 billion in annual sales and more than 400 licensed retailers, cultivators, and manufacturers. The state's Cannabis Control Commission oversees a regulatory framework that has generated over $500 million in cumulative tax revenue since adult-use sales began in November 2018. Any changes to this framework through a ballot initiative would immediately impact thousands of jobs, hundreds of small businesses, and the medical patients who rely on the state's parallel medical marijuana program serving approximately 75,000 registered patients. The ballot question arrives at a critical juncture for cannabis policy nationwide. With federal rescheduling under consideration by the DEA and neighboring states like New York, Connecticut, and Rhode Island building their own adult-use markets, Massachusetts policy decisions reverberate beyond state borders. Multi-state operators with significant Massachusetts footprints—including Curaleaf, Trulieve, and Verano—have invested hundreds of millions in cultivation facilities, processing operations, and retail locations across the Commonwealth. Changes to taxation, licensing, or market structure could trigger capital reallocation across the regional cannabis economy. Social equity remains a central concern. Massachusetts established one of the nation's first social equity programs for cannabis licensing, prioritizing applicants from communities disproportionately harmed by previous marijuana prohibition enforcement. The ballot question's provisions regarding licensing, market access, and equity program funding will determine whether Massachusetts expands opportunity for minority-owned businesses or consolidates market power among existing operators.

Background and History

Massachusetts cannabis policy evolved through three distinct ballot initiatives over two decades, creating the regulatory foundation now subject to voter modification in 2026.

2008: Medical Marijuana Initiative

Massachusetts voters approved Question 3 in November 2008 with 63% support, establishing the state's medical marijuana program. The initiative allowed patients with debilitating medical conditions to possess up to a 60-day supply of marijuana with physician certification. The law created a framework for nonprofit medical marijuana treatment centers, though implementation faced years of regulatory delays. The Department of Public Health did not issue final regulations until 2013, and the first dispensaries did not open until 2015. This seven-year gap between voter approval and operational dispensaries created frustration among patients and advocates, foreshadowing implementation challenges that would recur with adult-use legalization.

2012: Decriminalization Expansion

While not a ballot question, the Massachusetts Legislature in 2012 expanded the state's 2008 decriminalization law (which had made possession of one ounce or less a civil violation) to include additional protections and clarifications. This legislative action demonstrated growing acceptance of cannabis policy reform among elected officials, setting the stage for full legalization efforts.

2016: Adult-Use Legalization (Question 4)

On November 8, 2016, Massachusetts voters approved Question 4 with 53.7% support, legalizing adult-use marijuana for individuals 21 and older. The initiative allowed personal possession of up to one ounce in public and up to 10 ounces at home, permitted home cultivation of up to six plants per person (12 per household), and established a regulatory framework for commercial cultivation, manufacturing, testing, and retail sales. The 2016 law created the Cannabis Control Commission as an independent state agency to regulate the adult-use market, separate from the medical program initially overseen by the Department of Public Health. The initiative imposed a 10.75% state excise tax on retail sales (in addition to the standard 6.25% sales tax), with municipalities permitted to add a local option tax of up to 3%. Revenue allocation directed funds to implementation costs, public health programs, and municipalities hosting cannabis businesses. Question 4 included social consumption provisions that were never implemented, home delivery authorization later restricted by CCC regulations, and social equity language that became the foundation for the Commission's later equity programs. The law took effect December 15, 2016, with the first adult-use retail sales beginning November 20, 2018, at two licensed retailers.

2016-2024: Implementation and Market Maturation

The Cannabis Control Commission issued its first adult-use licenses in 2018 after developing comprehensive regulations covering security, testing, packaging, advertising, and social equity. The market grew rapidly from two retailers in November 2018 to over 400 licensed businesses by 2024, spanning cultivation, manufacturing, testing laboratories, retail, and delivery services. Key regulatory developments included the 2019 launch of the Social Equity Program, providing technical assistance and priority licensing review for applicants from communities with high rates of marijuana-related arrests; the 2020 approval of home delivery services; the 2021 expansion of social consumption pilot programs (though none were ultimately implemented); and ongoing debates over market concentration, vertical integration limits, and license caps. By 2024, Massachusetts had issued over 1,800 total licenses across all categories, though not all remained operational. The state collected over $150 million annually in cannabis tax revenue, with cumulative collections exceeding $500 million since adult-use sales began. The medical program continued operating in parallel, serving approximately 75,000 registered patients through 70+ medical dispensaries, many co-located with adult-use retail operations.

2024-2025: Petition Drive and Signature Gathering

The 2026 ballot question originated from a citizen petition drive that began in mid-2024. Massachusetts law requires initiative petitions to collect signatures equal to 3% of total votes cast for governor in the previous election—approximately 80,000 certified signatures—to qualify for the ballot. Petitioners must first submit initial signatures to local election officials for certification, then submit certified signatures to the Attorney General for legal review, and finally gather additional signatures if the initiative advances past legislative review. The marijuana question petition gathered signatures through fall 2024 and winter 2025, submitting initial signatures to the Attorney General in December 2024. After legal review confirming the petition met constitutional requirements, the measure advanced to the Legislature for consideration during the 2025 legislative session. The Massachusetts Constitution allows the Legislature to adopt, amend, or reject initiative petitions; if rejected or not acted upon, petitioners must gather additional signatures to place the question directly before voters. The Legislature took no action on the marijuana petition during the 2025 session, requiring petitioners to gather approximately 13,000 additional signatures by July 2025 to qualify for the November 2026 ballot. Petitioners submitted over 20,000 signatures, providing a cushion against invalid signatures during local certification.

2025-2026: Legal Challenges and Qualification

Between signature submission and ballot qualification, the marijuana question faced legal challenges from opponents arguing the petition violated the state constitution's single-subject rule or contained misleading language. The Massachusetts Supreme Judicial Court declined to remove the question from the ballot in a June 2026 ruling, finding the petition met constitutional requirements and presented a clear question to voters. In July 2026, Secretary of State William Galvin announced that all nine qualified ballot questions, including the marijuana measure, had received their official ballot numbers for the November election. The marijuana question's survival through signature verification and legal challenge positioned it for a four-month campaign period leading to the November 2026 vote.

Key Players

The 2026 ballot campaign involves state regulators, industry trade groups, social equity advocates, municipal officials, and opposition coalitions with competing visions for Massachusetts cannabis policy.

Cannabis Control Commission

The Cannabis Control Commission, established by the 2016 legalization initiative, serves as the independent regulatory authority for adult-use marijuana in Massachusetts. The five-member commission appointed by the governor oversees licensing, compliance, testing standards, social equity programs, and market monitoring. The CCC has taken no official position on the 2026 ballot question, maintaining regulatory neutrality while preparing to implement whatever policy voters approve. The commission's administrative capacity, regulatory expertise, and existing framework will shape implementation of any ballot question provisions.

Industry Trade Associations

The Massachusetts Cannabis Industry Association, representing over 200 licensed businesses, has emerged as a major stakeholder in the ballot campaign. The association's position depends on the specific provisions of the ballot question—supporting measures that expand market access and reduce regulatory burdens while opposing provisions that increase taxes or impose new restrictions. Multi-state operators including Curaleaf (headquartered in Massachusetts), Trulieve, and Verano hold significant market share and financial stakes in the outcome. The Commonwealth Dispensary Association, representing smaller retail operators, and the Massachusetts Growers Advocacy Council, representing craft cultivators, bring distinct perspectives based on business size and market segment. Social equity operators, many still navigating the licensing process or early operations, focus on provisions affecting equity program funding, technical assistance, and market access protections.

Social Equity Advocates

Organizations including the Minority Cannabis Business Association Massachusetts chapter and local community groups from Boston, Springfield, Worcester, and other cities with high historical arrest rates advocate for strengthening social equity provisions in any ballot measure. These groups emphasize that communities disproportionately harmed by prohibition enforcement should benefit from legalization through business ownership, employment, and community reinvestment. Their support or opposition to the ballot question hinges on whether provisions expand equity program resources and market access protections.

Municipal Officials

The Massachusetts Municipal Association, representing cities and towns across the state, focuses on local control provisions, tax revenue allocation, and community impact mitigation. Over 200 Massachusetts municipalities have voted to allow cannabis businesses, while approximately 150 have maintained local bans through municipal votes or zoning restrictions. Municipal officials seek clarity on local option tax authority, host community agreement requirements, and revenue-sharing formulas.

Public Health and Opposition Groups

Organizations including the Massachusetts Public Health Association, Smart Approaches to Marijuana Massachusetts chapter, and parent groups have historically opposed cannabis liberalization measures. These groups emphasize youth access prevention, impaired driving concerns, and public health impacts. Their campaign strategy typically focuses on undecided voters, suburban communities, and parents concerned about normalization of marijuana use.

Medical Patient Advocates

The Massachusetts Patient Advocacy Alliance and similar organizations represent the state's 75,000 registered medical marijuana patients. These advocates focus on protecting the medical program's distinct regulatory framework, maintaining lower tax rates for medical purchases, and ensuring patient access is not compromised by adult-use market changes. Medical patients pay no excise tax on purchases, a benefit worth approximately $100 annually for regular users.

Legal and Regulatory Framework

Massachusetts cannabis law operates under Chapter 94G of the General Laws, the Cannabis Control Commission's comprehensive regulations at 935 CMR 500.000, and municipal ordinances governing local licensing and zoning.

State Statutory Framework

Chapter 94G, enacted by the 2016 ballot initiative and subsequently amended by the Legislature, establishes the legal foundation for adult-use marijuana in Massachusetts. The statute authorizes personal possession of up to one ounce in public and 10 ounces in a residence, permits home cultivation of up to six plants per person (12 per household), and creates the regulatory structure for commercial licensing. The law establishes the Cannabis Control Commission as an independent agency within the state Treasurer's office, governed by a five-member commission with staggered terms. The statute requires the commission to issue regulations covering all aspects of the commercial market, prioritize social equity in licensing, and coordinate with the Department of Public Health on public health initiatives. Chapter 94G imposes a 10.75% excise tax on retail sales, collected by the commission and distributed according to statutory formulas. Revenue allocation directs funds first to commission operations, then to the Cannabis Social Equity Trust Fund, public health programs, and the General Fund. Municipalities may impose an additional local option tax of up to 3% on retail sales occurring within their borders.

Cannabis Control Commission Regulations

The CCC's regulations at 935 CMR 500.000 span over 300 pages covering licensing categories, application requirements, security standards, testing protocols, packaging and labeling requirements, advertising restrictions, social equity program criteria, and enforcement procedures. Key regulatory provisions include: License categories for marijuana retailers, cultivators, product manufacturers, testing laboratories, transporters, delivery operators, and microbusinesses (small-scale vertically integrated operations). Each category has distinct application requirements, fees, and operational standards. Social equity program provisions prioritizing applicants from areas with high rates of marijuana arrests, applicants who have drug convictions, or applicants from families with drug conviction histories. Social equity applicants receive technical assistance, priority application review, and reduced licensing fees. Testing requirements mandate that all marijuana products undergo testing for potency, pesticides, heavy metals, microbial contaminants, and residual solvents before retail sale. Products failing testing standards cannot be sold and must be destroyed or remediated. Packaging and labeling standards require child-resistant packaging, health warnings, potency disclosure, and prohibition of designs appealing to minors. Products cannot contain more than 5 milligrams of THC per serving or 100 milligrams per package for edibles. Advertising restrictions prohibit marketing on television, radio, or billboards where more than 15% of the audience is reasonably expected to be under 21, ban health or therapeutic claims for adult-use products, and require all advertising to include health warnings.

Municipal Authority

Massachusetts law grants municipalities significant local control over cannabis businesses. Cities and towns may vote to prohibit marijuana establishments within their borders through local ballot questions or municipal votes. Municipalities that allow cannabis businesses may impose zoning restrictions, limit the number of licenses, and negotiate host community agreements with applicants. Host community agreements typically require cannabis businesses to make annual payments to municipalities (often 3% of gross revenues, the maximum allowed under state law) and include provisions for community benefits, local hiring, and operational standards. These agreements must be approved by the Cannabis Control Commission as part of the licensing process. Over 200 Massachusetts municipalities have voted to allow cannabis businesses, though many impose strict zoning limitations or license caps. Approximately 150 municipalities maintain prohibition through local votes or zoning that effectively excludes cannabis operations.

Federal Law Interaction

Despite state legalization, marijuana remains a Schedule I controlled substance under the federal Controlled Substances Act at 21 U.S.C. § 812. This creates ongoing tensions between state-legal cannabis businesses and federal law, particularly regarding banking access, tax treatment under Internal Revenue Code Section 280E, and interstate commerce prohibition. Massachusetts cannabis businesses cannot deduct ordinary business expenses on federal tax returns due to 280E, which prohibits deductions for businesses trafficking in Schedule I or II controlled substances. This results in effective federal tax rates of 70% or higher for profitable cannabis companies. Banking access remains limited, with most national banks declining to serve cannabis clients due to federal money laundering concerns, forcing many businesses to operate primarily in cash. The potential federal rescheduling of marijuana to Schedule III, currently under DEA review following a Department of Health and Human Services recommendation, would eliminate 280E restrictions and provide significant tax relief to Massachusetts cannabis businesses. However, rescheduling would not legalize marijuana under federal law or resolve interstate commerce restrictions.

The 2026 Ballot Question: Provisions and Implications

While the specific text of the 2026 marijuana ballot question has not been fully disclosed in available sources, the measure likely addresses taxation, licensing, social equity, or market structure issues that have emerged during eight years of legal cannabis operations. Based on patterns in other state cannabis ballot initiatives and ongoing policy debates in Massachusetts, the 2026 question may include provisions related to: Tax rate adjustments, either increasing the excise tax to generate additional revenue for public programs or decreasing the tax to improve price competitiveness with the illicit market and neighboring states. Massachusetts' combined state and local tax burden of up to 20% (10.75% excise + 6.25% sales + 3% local option) ranks among the highest in the nation. Licensing reforms to address market access barriers, reduce application costs, or modify social equity program criteria. Some advocates have called for automatic license approval for applicants meeting objective criteria, elimination of net worth requirements that disadvantage small businesses, and expanded technical assistance funding. Social consumption authorization to permit on-site consumption at licensed establishments, similar to bars or cafes. The 2016 legalization law included social consumption language, but the Cannabis Control Commission never implemented regulations, citing concerns about workplace safety, impaired driving, and municipal opposition. Home cultivation modifications, either expanding the current six-plant-per-person limit or imposing new restrictions in response to concerns about large-scale home grows supplying the illicit market. Some municipalities have sought authority to ban home cultivation, currently prohibited by state law. Expungement and criminal justice provisions to automatically seal or expunge prior marijuana convictions, expand eligibility criteria, or create new pathways for record relief. Massachusetts enacted limited expungement provisions in 2018, but advocates argue the process remains too burdensome and excludes many individuals with distribution convictions.

Market and Business Implications

The ballot question outcome will directly impact the financial performance of Massachusetts' $1.5 billion cannabis market, affecting multi-state operators, craft cultivators, and social equity applicants competing for market share.

Multi-State Operator Exposure

Publicly traded cannabis companies with significant Massachusetts operations face material financial risk from ballot question provisions. Curaleaf, headquartered in Wakefield, Massachusetts, operates multiple cultivation facilities and retail locations across the state, with Massachusetts representing approximately 15-20% of total company revenue. Trulieve, Verano, and other MSOs have invested tens of millions in Massachusetts infrastructure and licenses. Tax increases would compress margins already pressured by 280E federal tax treatment and wholesale price deflation. Massachusetts wholesale cannabis prices declined approximately 40% between 2020 and 2024 as cultivation capacity expanded faster than demand growth. Retail prices similarly declined, with average per-gram prices falling from $15 in 2019 to $10 in 2024. Additional tax burden would force operators to either absorb margin compression or pass costs to consumers, risking market share loss to lower-priced illicit suppliers. Licensing reforms expanding market access would increase competition, potentially fragmenting market share currently concentrated among the largest operators. The top 10 cannabis companies in Massachusetts control approximately 40% of retail sales, with Curaleaf alone accounting for roughly 8-10% of statewide revenue. New license issuance without corresponding demand growth would intensify price competition and reduce per-store revenue.

Craft Cultivator and Microbusiness Impact

Small-scale cultivators and microbusinesses (vertically integrated operations under 5,000 square feet of canopy) face distinct challenges and opportunities from ballot question provisions. These operators typically lack the capital reserves of MSOs, making them more vulnerable to regulatory changes that increase compliance costs or reduce margins. Tax reductions would disproportionately benefit smaller operators by improving price competitiveness against larger competitors with economies of scale. Craft cultivators often position products as premium or artisanal, commanding higher prices that become less competitive as taxes increase the total consumer cost. Social equity program expansions could provide crucial technical assistance, reduced fees, and market access protections for craft operators, many of whom qualify as social equity applicants. However, increased competition from new entrants could fragment an already crowded market where many small operators struggle to achieve profitability.

Real Estate and Ancillary Services

Cannabis real estate investors, equipment suppliers, testing laboratories, and professional services firms face indirect exposure to ballot question outcomes. Massachusetts cannabis facilities occupy millions of square feet of industrial and retail space, with lease rates typically 20-40% above market for comparable non-cannabis properties due to landlord risk premiums and tenant demand. Market contraction from tax increases or regulatory restrictions would reduce demand for cannabis-specific real estate, potentially creating vacancies in secondary markets where cannabis has driven industrial property absorption. Conversely, licensing expansions would increase demand for compliant facilities, benefiting property owners and developers. Testing laboratories, security companies, compliance consultants, and other ancillary service providers would see revenue impacts correlated with overall market activity. Massachusetts supports approximately 15 licensed testing laboratories and hundreds of ancillary businesses dependent on cannabis industry spending.

Tax Revenue Projections

Massachusetts collected approximately $150 million in cannabis excise and sales tax revenue in fiscal year 2024, with cumulative collections exceeding $500 million since adult-use sales began. Revenue allocation under current law directs funds to Cannabis Control Commission operations (approximately $30 million annually), the Cannabis Social Equity Trust Fund, public health programs, and the General Fund. Tax rate increases could generate an additional $20-50 million annually depending on magnitude and demand elasticity. However, economic research suggests cannabis demand is moderately price-elastic, with a 10% price increase reducing consumption by approximately 5-8%. Tax increases that push total prices significantly above illicit market rates could reduce legal sales and tax revenue while strengthening illegal suppliers. Tax rate decreases would reduce revenue in the short term but could expand the legal market by improving price competitiveness, potentially offsetting revenue losses through volume growth. States including Illinois and Washington have debated similar tradeoffs as mature markets face price compression and illicit market competition.

What Experts Say

Cannabis policy analysts, economists, and legal scholars have examined Massachusetts' market maturation and identified key considerations for voters evaluating the 2026 ballot question. The RAND Corporation's research on cannabis taxation suggests that Massachusetts' combined tax rate approaches the threshold where legal market prices become uncompetitive with illicit suppliers, particularly for price-sensitive consumers. RAND economists have noted that optimal cannabis tax rates balance revenue generation against illegal market suppression, typically falling in the 15-25% range depending on local market conditions and enforcement intensity. The Marijuana Policy Project, a national cannabis reform organization, has emphasized that Massachusetts' social equity program, while pioneering, has faced implementation challenges including insufficient funding, lengthy licensing timelines, and difficulty accessing capital. Policy analysts from the organization have stated that meaningful social equity requires not just licensing priority but also access to capital, technical assistance, and market protections against consolidation by well-funded competitors. Boston University School of Public Health researchers studying cannabis use patterns in Massachusetts have found that legalization did not significantly increase youth use rates, which have remained stable or declined slightly since 2016. However, public health experts have noted increased adult use, higher-potency product availability, and emergency department visits related to cannabis, suggesting ongoing need for public health monitoring and education programs. The Massachusetts Taxpayers Foundation, a nonpartisan fiscal policy organization, has analyzed cannabis tax revenue and noted that collections have grown steadily but remain a small fraction of total state revenue (less than 1%). The foundation's analysts have observed that cannabis tax revenue volatility and uncertainty make it unsuitable as a primary funding source for essential services, suggesting that revenue allocation should prioritize one-time investments or reserve funds rather than ongoing program commitments. New Frontier Data, a cannabis market research firm, has projected that Massachusetts adult-use sales will reach $1.8-2.0 billion by 2027 under current policy, with growth driven primarily by consumer migration from the illicit market and neighboring states rather than increased per-capita consumption. The firm's analysts have noted that market maturation typically brings price deflation, margin compression, and industry consolidation, patterns evident in Massachusetts' trajectory.

What's Next

The November 2026 election will determine the ballot question outcome, followed by a legislative implementation period and Cannabis Control Commission rulemaking to operationalize any approved changes.

Campaign Period: July-November 2026

The four-month campaign period will feature competing messaging from supporters and opponents, with spending likely to reach $10-20 million based on patterns in other state cannabis ballot campaigns. Key campaign activities will include television and digital advertising, grassroots organizing, coalition building, and voter education efforts. Polling will provide ongoing insight into voter sentiment, with particular attention to suburban swing voters, communities of color affected by prohibition enforcement, and younger voters with high support for cannabis reform. Massachusetts ballot questions typically require 50% plus one vote for approval, with no minimum turnout threshold. The presence of eight other ballot questions competing for voter attention will complicate campaign messaging and may reduce voter engagement with the marijuana question. Ballot fatigue—voter tendency to skip questions later on the ballot or vote "no" when uncertain—could disadvantage the cannabis measure depending on its ballot position.

Post-Election Implementation

If voters approve the ballot question, implementation will follow a timeline determined by the measure's effective date provisions. Massachusetts ballot initiatives typically take effect 30 days after the election unless otherwise specified. However, complex regulatory changes often require months or years for full implementation. The Cannabis Control Commission would begin rulemaking to implement ballot question provisions, following the state's administrative procedure requirements including public comment periods, stakeholder input, and legal review. Regulatory development for major policy changes typically requires 6-12 months before new rules take effect. Legislative action may follow if the ballot question creates ambiguities, conflicts with existing law, or requires statutory changes beyond the initiative's scope. The Massachusetts Legislature has previously amended voter-approved cannabis laws, including significant revisions to the 2016 legalization initiative in 2017 that increased the tax rate and modified regulatory structure.

Key Dates and Decision Points

• November 5, 2026: Election Day; ballot question vote
• December 5, 2026: Approximate effective date (30 days post-election) if question passes
• Q1 2027: Cannabis Control Commission begins rulemaking process
• Q2-Q3 2027: Public comment periods and stakeholder input on proposed regulations
• Q4 2027: Final regulations adopted; implementation begins
• 2028: Full implementation of ballot question provisions

Scenarios and Outcomes

Approval of the ballot question would trigger the implementation timeline described above, with specific impacts depending on the measure's provisions. Tax increases would take effect relatively quickly, while licensing reforms or social consumption authorization would require extensive regulatory development. Rejection of the ballot question would maintain the current regulatory framework, though the Legislature could subsequently enact cannabis policy changes through the normal legislative process. Ballot question defeat often signals voter satisfaction with the status quo or concerns about specific provisions, potentially chilling legislative reform efforts. Close vote margins (within 5 percentage points) would suggest divided public opinion and potential for future ballot initiatives or legislative action. Massachusetts cannabis policy has evolved through multiple ballot questions over two decades, and the 2026 vote is unlikely to be the final word on cannabis regulation in the Commonwealth.

Further Reading

• Massachusetts Cannabis Control Commission official website: https://masscannabiscontrol.com
• Chapter 94G of the Massachusetts General Laws (cannabis statute): https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXV/Chapter94G
• 935 CMR 500.000 (Cannabis Control Commission regulations): https://www.mass.gov/regulations/935-CMR-50000-adult-use-of-marijuana
• Massachusetts Secretary of State Elections Division: https://www.sec.state.ma.us/ele/
• Cannabis Control Commission Social Equity Program: https://masscannabiscontrol.com/equityprograms/
• Massachusetts Department of Public Health Medical Marijuana Program: https://www.mass.gov/medical-use-of-marijuana-program
• 2016 Question 4 ballot initiative text and results: https://www.sec.state.ma.us/ele/ele16/ballot_questions_16/quest4.htm
• RAND Corporation cannabis policy research: https://www.rand.org/topics/cannabis.html
• Marijuana Policy Project Massachusetts page: https://www.mpp.org/states/massachusetts/
• New Frontier Data cannabis market research: https://newfrontierdata.com